Asim Farooq to Antibodies, Monoclonal, Humanized
This is a "connection" page, showing publications Asim Farooq has written about Antibodies, Monoclonal, Humanized.
Connection Strength
0.301
-
Practical Guidance on Clinical Management of Belantamab Mafodotin-Associated Ocular Events. Am J Hematol. 2025 Oct; 100(10):1839-1850.
Score: 0.151
-
Management of belantamab mafodotin-associated corneal events in patients with relapsed or refractory multiple myeloma (RRMM). Blood Cancer J. 2021 05 26; 11(5):103.
Score: 0.113
-
Characterization of Belantamab Mafodotin-Induced Corneal Changes in Patients With Multiple Myeloma. JAMA Ophthalmol. 2025 06 01; 143(6):507-514.
Score: 0.037